Dependence/NN
for/IN
the/DT
proliferative/JJ
response/NN
to/TO
erythropoietin/NN
on/IN
an/DT
established/JJ
erythroid/JJ
differentiation/NN
program/NN
in/IN
a/DT
human/JJ
hematopoietic/JJ
cell/NN
line/NN
,/,
UT-7/NN
./.

Erythroid/JJ
differentiation/NN
involves/VBZ
the/DT
activation/NN
of/IN
a/DT
number/NN
of/IN
erythroid-specific/JJ
genes/NNS
,/,
most/JJS
of/IN
which/WDT
,/,
including/VBG
the/DT
globin/NN
genes/NNS
and/CC
the/DT
erythropoietin/NN
receptor/NN
(/(
Epo-R/NN
)/)
gene/NN
,/,
are/VBP
,/,
at/IN
least/JJS
in/IN
part/NN
,/,
regulated/VBN
by/IN
the/DT
transcription/NN
factor/NN
GATA-1/NN
./.
=====
In/IN
order/NN
to/TO
understand/VB
the/DT
relationship/NN
,/,
if/IN
any/DT
,/,
between/IN
expression/NN
of/IN
GATA-1/NN
,/,
response/NN
to/TO
Epo/NN
and/CC
erythroid/JJ
differentiation/NN
,/,
we/PRP
analyzed/VBD
the/DT
expression/NN
of/IN
GATA-1/NN
,/,
Epo-R/NN
and/CC
globin/NN
genes/NNS
in/IN
an/DT
Epo-dependent/JJ
human/JJ
cell/NN
line/NN
,/,
UT-7/NN
Epo/NN
./.
=====
The/DT
results/NNS
were/VBD
compared/VBN
to/TO
those/DT
obtained/VBN
with/IN
the/DT
parental/JJ
granulocyte-macrophage/JJ
colony-stimulating/JJ
factor/NN
(/(
GM-CSF/NN
)/)
-dependent/JJ
cell/NN
line/NN
,/,
UT-7/NN
,/,
which/WDT
has/VBZ
a/DT
predominantly/RB
megakaryoblastic/JJ
phenotype/NN
and/CC
is/VBZ
unable/JJ
to/TO
proliferate/VB
continuously/RB
in/IN
the/DT
presence/NN
of/IN
Epo/NN
./.
=====
UT-7/NN
Epo/NN
and/CC
UT-7/NN
expressed/VBD
similar/JJ
levels/NNS
of/IN
GATA-1/NN
mRNA/NN
and/CC
binding/NN
activity/NN
./.
=====
The/DT
two/CD
lines/NNS
also/RB
expressed/VBD
comparable/JJ
levels/NNS
of/IN
Epo-R/NN
mRNA/NN
while/IN
the/DT
number/NN
of/IN
Epo-binding/JJ
sites/NNS
on/IN
UT-7/NN
Epo/NN
cells/NNS
was/VBD
one-sixth/CD
the/DT
number/NN
of/IN
UT-7/NN
cells/NNS
(/(
2400/CD
+/-/CC
3/CD
vs./CC
13/CD
,/,
800/CD
+/-/CC
300/CD
)/)
./.
=====
This/DT
difference/NN
in/IN
the/DT
number/NN
of/IN
binding/VBG
sites/NNS
could/MD
be/VB
due/JJ
to/TO
differences/NNS
in/IN
cell/NN
surface/NN
(/(
UT-7/NN
cells/NNS
are/VBP
20/CD
%/NN
smaller/JJR
than/IN
the/DT
parental/JJ
UT-7/NN
cells/NNS
)/)
or/CC
in/IN
receptor/NN
turnover/NN
./.
=====
By/IN
Northern/NN
analysis/NN
,/,
UT-7/NN
cells/NNS
expressed/VBD
detectable/JJ
levels/NNS
of/IN
beta-/NN
and/CC
gamma-globin/NN
but/CC
not/RB
alpha-globin/NN
./.
=====
In/IN
comparison/NN
,/,
UT-7/NN
Epo/NN
cells/NNS
expressed/VBD
alpha-globin/NN
and/CC
higher/JJR
levels/NNS
of/IN
gamma-globin/NN
(/(
5-fold/JJ
)/)
and/CC
beta-globin/NN
(/(
from/IN
barely/RB
to/TO
clearly/RB
detectable/JJ
)/)
./.
=====
Globin/NN
chains/NNS
(/(
alpha/NN
,/,
beta/NN
and/CC
gamma/NN
)/)
were/VBD
clearly/RB
detectable/JJ
by/IN
affinity/NN
chromatography/NN
in/IN
UT-7/NN
Epo/NN
but/CC
not/RB
in/IN
UT-7/NN
cells/NNS
./.
=====
The/DT
frequency/NN
of/IN
the/DT
cells/NNS
which/WDT
expressed/VBD
beta-/NN
and/CC
gamma-globin/NN
genes/NNS
in/IN
the/DT
two/CD
cell/NN
populations/NNS
was/VBD
measured/VBN
by/IN
immunofluorescence/NN
with/IN
beta-/NN
and/CC
gamma-specific/JJ
antibodies/NNS
./.
=====
The/DT
number/NN
of/IN
gamma-positive/JJ
cells/NNS
and/CC
their/PRP$
fluorescence/NN
intensity/NN
were/VBD
higher/JJR
in/IN
UT-7/NN
Epo/NN
than/IN
in/IN
UT-7/NN
cells/NNS
(/(
0/CD
to/TO
17/CD
%/NN
barely/RB
positive/JJ
cells/NNS
and/CC
23/CD
to/TO
40/CD
%/NN
clearly/RB
positive/JJ
cells/NNS
,/,
respectively/RB
)/)
,/,
indicating/VBG
that/IN
the/DT
increase/NN
in/IN
globin/NN
mRNA/NN
observed/VBN
in/IN
UT-7/NN
Epo/NN
is/VBZ
due/JJ
to/TO
both/CC
an/DT
increase/NN
of/IN
gene/NN
expression/NN
per/IN
cell/NN
and/CC
an/DT
increase/NN
in/IN
numbers/NNS
of/IN
cells/NNS
containing/VBG
gamma-globin/NN
./.
=====
The/DT
levels/NNS
of/IN
GATA-1/NN
,/,
Epo-R/NN
and/CC
globin/NN
mRNA/NN
expressed/VBN
were/VBD
not/RB
affected/VBN
by/IN
a/DT
24-hour/JJ
incubation/NN
of/IN
either/CC
cell/NN
line/NN
with/IN
Epo/NN
,/,
GM-CSF/NN
or/CC
interleukin-3/NN
(/(
IL-3/NN
)/)
./.
=====
(/(
ABSTRACT/NN
TRUNCATED/VBN
AT/IN
400/CD
WORDS/NNS
)/)